Research Article
Pregnancy in Sickle Cell Disease Is a Very High-Risk Situation: An Observational Study
Table 5
Comparison of maternal-fetal characteristics between transfused and nontransfused pregnant women with sickle cell disease during pregnancy.
| | | Nontransfused () | Transfused () | |
| | Median age (years) | 25.9 (16–40) | 26 (17–41) | 0.7 | | Pregestational Hb (g/dL) | 9.9 (8.4–11.4) | 8.7 (7.1–10.7) | 0.06 | | Abnormal fetal heart rate (%) | 6 () | 3 () | 0.4 | | Preterm labor (%) | 4 () | 3 () | 0.3 | | Preeclampsia (%) | 5 () | 6 () | 0.8 | | Fetal death in utero (%) | 1 () | 2 () | 0.5 | | Intrauterine growth retardation (%) | 8 (24.2) | 7 (24.1) | 0.9 | | Maternal hospitalization in ICU (%) | 5 () | 5 () | 0.8 | | Maternal death (%) | 0 | 0 | | | Total death (maternal and fetal) (%) | 0 | 0 | | | Prematurity (%) | 6 () | 12 (41) | 0.04 |
|
|
